Cipla Therapeutics partners with SIGA Technologies for antibacterial drugs
Cipla Therapeutics, an Indian pharma company, and SIGA Technologies have entered into a partnership to provide sustained innovation and access to novel antibacterial drugs, especially ... Read More
Siga Technologies secures Tecovirimat FDA approval for smallpox treatment
Siga Technologies has achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of its orally administered antiviral drug, TPOXX (tecovirimat), for ... Read More